324 related articles for article (PubMed ID: 21479319)
21. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
[TBL] [Abstract][Full Text] [Related]
22. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
Thomas T; Bahadori T; Savage N; Thomas K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
[TBL] [Abstract][Full Text] [Related]
23. Toxicological aspects for nanomaterial in humans.
Dusinska M; Magdolenova Z; Fjellsbø LM
Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
[TBL] [Abstract][Full Text] [Related]
24. Toxicity assessment of manufactured nanomaterials using the unicellular green alga Chlamydomonas reinhardtii.
Wang J; Zhang X; Chen Y; Sommerfeld M; Hu Q
Chemosphere; 2008 Oct; 73(7):1121-8. PubMed ID: 18768203
[TBL] [Abstract][Full Text] [Related]
25. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
Thomas K; Sayre P
Toxicol Sci; 2005 Oct; 87(2):316-21. PubMed ID: 16049265
[TBL] [Abstract][Full Text] [Related]
26. The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants.
Musee N; Thwala M; Nota N
J Environ Monit; 2011 May; 13(5):1164-83. PubMed ID: 21505709
[TBL] [Abstract][Full Text] [Related]
27. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
[TBL] [Abstract][Full Text] [Related]
28. Acute effects of Fe₂O₃, TiO₂, ZnO and CuO nanomaterials on Xenopus laevis.
Nations S; Wages M; Cañas JE; Maul J; Theodorakis C; Cobb GP
Chemosphere; 2011 May; 83(8):1053-61. PubMed ID: 21345480
[TBL] [Abstract][Full Text] [Related]
29. Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials.
Thomas K; Aguar P; Kawasaki H; Morris J; Nakanishi J; Savage N
Toxicol Sci; 2006 Jul; 92(1):23-32. PubMed ID: 16687392
[TBL] [Abstract][Full Text] [Related]
30. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
31. Nanotechnology and public health.
Matsudai M; Hunt G
Nihon Koshu Eisei Zasshi; 2005 Nov; 52(11):923-7. PubMed ID: 16408476
[TBL] [Abstract][Full Text] [Related]
32. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells.
Kumar A; Pandey AK; Singh SS; Shanker R; Dhawan A
Chemosphere; 2011 May; 83(8):1124-32. PubMed ID: 21310462
[TBL] [Abstract][Full Text] [Related]
33. Nanomaterials and lab-on-a-chip technologies.
Medina-Sánchez M; Miserere S; Merkoçi A
Lab Chip; 2012 May; 12(11):1932-43. PubMed ID: 22517169
[TBL] [Abstract][Full Text] [Related]
34. Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles.
Morgan K
Risk Anal; 2005 Dec; 25(6):1621-35. PubMed ID: 16506988
[TBL] [Abstract][Full Text] [Related]
35. Nanotoxicity: a growing need for study in the endocrine system.
Lu X; Liu Y; Kong X; Lobie PE; Chen C; Zhu T
Small; 2013 May; 9(9-10):1654-71. PubMed ID: 23401134
[TBL] [Abstract][Full Text] [Related]
36. [Health risks of engineered nanomaterials and nanotechnologies].
Savolainen K; Vainio H
Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
[TBL] [Abstract][Full Text] [Related]
37. Nanomaterial health effects part 3: conclusion--hazardous issues and the precautionary principle.
Kanarek MS
WMJ; 2007 Feb; 106(1):16-9. PubMed ID: 17393752
[TBL] [Abstract][Full Text] [Related]
38. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
39. Nanomaterial health effects--part 1: background and current knowledge.
Powell MC; Kanarek MS
WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
[TBL] [Abstract][Full Text] [Related]
40. Modeled environmental concentrations of engineered nanomaterials (TiO(2), ZnO, Ag, CNT, Fullerenes) for different regions.
Gottschalk F; Sonderer T; Scholz RW; Nowack B
Environ Sci Technol; 2009 Dec; 43(24):9216-22. PubMed ID: 20000512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
